The emergence of SARS-CoV-2 virus and the disease it causes, COVID-19, have fuelled significant shifts in preclinical research across the globe. Amid the worldwide health emergency created by high infection rates, rapid transmission spread and relatively high mortality rates, researchers are under pressure to understand the disease’s pathogenesis, develop and test investigational therapeutics and explore viable vaccine approaches.
Join FREE today and become a member
of Drug Discovery World
- Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
- Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
- Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
- Whitepapers, eBooks and information from trusted third parties.